Hemophilia Arthropathy
8
1
1
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (8)
Prevalence of Synovitis in Patients With Haemophilia A
Physiotherapy and Reaction Time in Hemophilia
Clinical, Functional and Musculoskeletal Differences Between Adult Patients With Hemophilia and Their Healthy Peers
Pain and Joint Status With Psychosocial Factors in Patients With Hemophilia
COVID-19 Quarantine on Musculoskeletal Status in Hemophilia
Effect of Exercise in Pediatric Hemophilia
Quality of Life in Hemophilia by Clinical Scoring System (FISH)Score
Pain in Patients With Congenital Coagulopathies